Session 2 - Pharmacological Treatment and medical considerations related to BFRBs

After Session 2, participants should be able to:

  • Identify which pharmacotherapy options show potential benefit in treating BFRBs
  • Identify common co-occurring conditions in HPD and SPD
  • Identify when is would be most appropriate to use N-acetyl cysteine, SSRIs and/or other psychotropic agents to treat BFRBs and comorbid conditions
  • Describe the psychiatric and medical differential for HPD and SPD, and identify possible medical sequelae from BFRBs

Target Audience

This program is intended for:

  • Physicians
  • Psychiatrists
  • Psychologists
  • Social Workers
  • Licensed Mental Health Counselors
  • Nurses
Course summary
Course opens: 
01/15/2019
Course expires: 
12/31/2021
Rating: 
0
Please login or register to take this course.